VeriMominositol hamilelikte güvenli mi?
No harmonised ECHA reproductive classification was found for myo‑inositol (CAS 87‑89‑8) and the Cosmetic Ingredient Review (CIR) draft safety assessment (June 2024) reviews inositol use in cosmetics and focuses on local/topical effects, concluding systemic exposure from cosmetics is much lower than dietary/medical exposures. Clinical literature shows myo‑inositol has been studied as an oral supplement during pregnancy (e.g., trials/meta‑analyses of gestational diabetes prevention) without signals of teratogenicity, indicating therapeutic/oral use rather than topical cosmetic use is not associated with reproductive hazard in humans. Sources: CIR safety assessment; PubMed meta‑analyses; ECHA registration summary.
Pregnancy-safe products containing inositol
Related ingredients
Frequently asked questions
- inositol hamilelikte güvenli mi?
- No harmonised ECHA reproductive classification was found for myo‑inositol (CAS 87‑89‑8) and the Cosmetic Ingredient Review (CIR) draft safety assessment (June 2024) reviews inositol use in cosmetics and focuses on local/topical effects, concluding systemic exposure from cosmetics is much lower than dietary/medical exposures. Clinical literature shows myo‑inositol has been studied as an oral supplement during pregnancy (e.g., trials/meta‑analyses of gestational diabetes prevention) without signals of teratogenicity, indicating therapeutic/oral use rather than topical cosmetic use is not associated with reproductive hazard in humans. Sources: CIR safety assessment; PubMed meta‑analyses; ECHA registration summary.
- inositol emzirirken güvenli mi?
- No evidence of reproductive or lactation‑specific hazard from topical inositol use was identified. Clinical/peer‑reviewed studies address oral supplementation (systemic use) in pregnancy with no flagged lactation/teratogenic concerns; CIR explicitly frames cosmetic topical exposure as primarily local and low systemic. No harmonised CLP classification or SCCS/Safety opinion contraindicating use in lactation was found.
- inositol bebek cildi için güvenli mi?
- No infant‑specific hazard or developmental toxicity evidence for inositol applied topically to infants (0–3 y) was found. CIR states topical exposures are low; however, because inositol is water‑soluble and not completely non‑absorbable, immature infant skin gives higher per‑kg exposure, so exposure score is increased by +1 for baby skin while hazard and mechanism remain 0 absent infant‑specific adverse data.
- VeriMom inositol nasıl puanlıyor?
- VeriMom inositol'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte inositol yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.